Medscape Conference Coverage, based on selected sessions at the:

6th World Stroke Congress

September 24 - 27, 2008; Vienna, Austria

This activity is not sanctioned by, nor a part of, the World Stroke Organization. Conference news does not receive grant support and is produced independently.

Expert Interview

Conference News

  • Mirror Therapy May Facilitate Recovery in Hemiplegic Stroke Patients

    Mirror therapy, a strategy that has been used successfully to treat phantom pain, may promote recovery from hemiplegia after a stroke, a new study suggests.Medscape Medical News, October 15, 2008
  • ECASS 3 Gets a Warm Welcome From the Stroke Community

    Results of the ECASS 3 trial showing a benefit from tPA treatment out to 4.5 hours had stroke experts at the World Stroke Congress calling for wider use of thrombolytic therapy. The results, they say, should give even skeptics more confidence to treat.Medscape Medical News, October 2, 2008
  • Novel Thrombolytic Microplasmin Safe in Acute Ischemic Stroke

    Results of a phase 2 trial showed safety with microplasmin in patients with acute ischemic stroke treated between 4 and 12 hours, with no increase in bleeding vs placebo.Medscape Medical News, October 2, 2008
  • Low Risk from Asymptomatic Carotid Stenosis With Intensive Medical Therapy

    New data from 1 center's series of patients with asymptomatic carotid stenosis have shown that institution of intensive medical therapy in 2003 has reduced plaque progression, microemboli, and cardiovascular events to levels below the threshold of risk associated with carotid stenting or surgery.Medscape Medical News, September 29, 2008

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the World Stroke Organization. These materials and the related activity are not sanctioned by the World Stroke Organization or the commercial supporter of the conference and do not constitute an official part of that conference.